echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > Top 20 research and development investment of global life science instrument companies

    Top 20 research and development investment of global life science instrument companies

    • Last Update: 2014-07-16
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Source: bioscover 2014-07-16 US journal of genetic engineering & Biotechnology news (Gen) According to the market report, the growing demand of various research and pharmaceutical companies, the increasing incidence of new and drug-resistant diseases promote the growth of life science tool market, while the life tool market needs sufficient R & D investment to continue to provide strong innovation Compared with the list a year ago, the R & D investment of life science tool market and technology has only changed a few times But these changes are huge: Life tech was acquired by Thermo Fisher Scientific for us $13.6 billion, plus US $1.5 billion of debt, and the acquisition agreement was signed on February 2 this year; on February 18, 2013, Shenzhen Huada gene completed the acquisition of complete genomics for us $117.6 million As a result, life tech and complete genomics are not on this year's top 20 list Roche – diagnostics division ranked first in the list In 2013, R & D expenditure exceeded US $1.2 billion, followed by GE Healthcare In 2013, R & D expenditure was about US $1 billion, Agilent Technologies ranked third, R & D expenditure in 2013 was more than US $700 million, BD ranked fourth, and Danaher Life Science & diagnostics Department ranked third (Danaher Life Sciences & Diagnostics) just made it into the top five, while semefei was sixth At the same time, in the past year, the R & D investment of 13 life science instrument companies has increased in varying degrees, including 5 companies with a growth rate of more than two digits, the largest one is Illumina, with a year-on-year growth of 19.8% in 2013 In addition, the R & D investment of five companies including Merck millipore, Bruker and sigma Aldrich showed a decline, among which Affymetrix dropped the most, with a year-on-year drop of 17.6% in 2013  
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.